Skip to content

    Recently Viewed


      A cartoon illustration of pie, bar and other graphs

      What you need to know about Johnson & Johnson’s 2021 fourth-quarter and full-year earnings report

      Check out this infographic breakdown of the company’s fourth-quarter and annual performance, with highlights from its Consumer Health, Pharmaceutical and Medical Devices businesses.

      Share Article
      share to

      Today, Johnson & Johnson shared its 2021 fourth-quarter and full-year earnings report.

      Since its founding in 1886, the company has grown to become one of the world’s largest and most broadly based healthcare companies, with approximately 136,000 employees across the globe working every day to help change the trajectory of health for humanity.

      “Johnson & Johnson’s strong 2021 fourth-quarter and full-year results were driven by the relentless agility, resilience and commitment of our global colleagues,” says Joe Wolk, Executive Vice President and Chief Financial Officer, Johnson & Johnson. “We are well-positioned for the year ahead with a continued focus on optimizing our core businesses and investing in a robust pipeline of breakthrough innovations across the enterprise.”

      For more details about the company’s 2021 fourth-quarter and full-year results, and to read a message from Chief Executive Officer Joaquin Duato, here’s an infographic highlighting key stats.

      Johnson & Johnson EOY Q4 2021 Earnings infographic

      Want to see more company earnings information? Find Johnson & Johnson’s past quarterly and full-year results here.

      More from Johnson & Johnson

      Blue latex-gloved hands holding a beaker filled with yellow liquid

      IBD rates are rising in communities of color. Can these innovators help?

      Scientists aren’t sure what’s behind the upward trend. That’s why Johnson & Johnson Innovation put out the call to address this troubling health disparity.
      DNA illustration genetic material

      Harnessing the human genome is the future of healthcare—and Johnson & Johnson is helping lead the way

      The company’s partnership with the largest human genome sequencing project in the world will increase scientists’ understanding of genetic diseases and help create new interventions. Here, a look at the breakthroughs that have guided the understanding of the power of DNA.
      Health & wellness
      1123 BTN-Lung Cancer-Iede2.jpg
      Health & wellness

      By the numbers: Who gets lung cancer?

      Each year, more people die of lung cancer than colon, breast and prostate cancers combined. Learn how Johnson & Johnson is dedicated to improving outcomes by integrating the company’s MedTech and Innovative Medicine expertise.
      You are now leaving and going to a site with a different privacy policy. Please click below to continue to that site.